Clinical Trial Update: Niclosamide for Familial Adenomatous Polyposis [Phase 2]

View source ↗

Summary

Phase 2 trial update for niclosamide in familial adenomatous polyposis (FAP) is reported with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Adenomatous Polyposis

Drugs mentioned

• Niclosamide (niclosamide)

Snippet

Sponsor: Yonsei University | Conditions: Familial Adenomatous Polyposis | Phase 2 | Status: UNKNOWN